References
- WHO. Immunization. Dec 5 2019 [cited 2022 Aug 16]. Available from: https://www.who.int/news-room/facts-in-pictures/detail/immunization
- WHO. The case for investing in public health. 2014 [cited 2021 Aug 24]. Available from: https://www.euro.who.int/__data/assets/pdf_file/0009/278073/Case-Investing-Public-Health.pdf
- Annemans L, Beutels P, Bloom DE, et al. Economic evaluation of vaccines: Belgian reflections on the need for a broader perspective. Value Health. 2021 Jan;24(1):105–111. doi: 10.1016/j.jval.2020.09.005
- Faivre P, Bencina G, Campbell R, et al. Immunization funding across 28 European countries. Expert Rev Vaccines. 2021 Jun;20(6):639–647. doi: 10.1080/14760584.2021.1905257
- Carrico J, La EM, Talbird SE, et al. Value of the immunization program for children in the 2017 US birth cohort. Pediatrics. 2022;150(3):e20210560. doi: 10.1542/peds.2021-056007
- Zhou F, Shefer A, Wenger J, et al. Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics. 2014 Apr;133(4):577–585. doi: 10.1542/peds.2013-0698
- Carrico J, Mellott CE, Talbird SE, et al. Public health impact and return on investment of Belgium’s pediatric immunization program. Front Public Health. 2023;11:1032385. doi: 10.3389/fpubh.2023.1032385
- Chief Sanitary Inspectorate. Vaccination Program for 2021. 2020 [cited 2023 Jan 5]. Available from: https://www.gov.pl/web/gis/program-szczepien-ochronnych-na-rok-2021
- NIZP-PZH. 2018 [cited2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2018/Sz_2018.pdf
- MZ. 2020. [cited 2020 Oct 19]. Available from: https://www.zzpprzymz.pl/przetargi/
- AOTMiT. Guidelines for health technology assessment. 2016. [cited 2020 Aug 27]. Available from: http://www.aotm.gov.pl/www/wp-content/uploads/wytyczne_hta/2016/20161104_HTA_Guidelines_AOTMiT.pdf
- OECD. Ppps and exchange rates: 2020. OECD National Accounts Statistics (database):2022. [cited 2022 Sep 26]. Available from: https://www.oecd-ilibrary.org/content/data/data-00004-en
- Zarządzenie Prezesa. NFZ nr 97/2020/DSOZ.2020. [cited 2020 Aug 5]. Available from: https://www.nfz.gov.pl/zarzadzenia-prezesa/zarzadzenia-prezesa-nfz/zarzadzenie-nr-972020dsoz,7200.html
- Zarządzenie Prezesa. NFZ nr 25/2020/DSOZ.2020. [cited 2020 Aug 5]. Available from: https://www.nfz.gov.pl/zarzadzenia-prezesa/zarzadzenia-prezesa-nfz/zarzadzenie-nr-252020dsoz,7136.html
- Zarządzenie Prezesa. NFZ nr 167/2019/DSOZ. 2019. [cited 2020 Aug 5]. Available from: https://www.nfz.gov.pl/zarzadzenia-prezesa/zarzadzenia-prezesa-nfz/zarzadzenie-nr-1672019dsoz,7081.html
- NIZP-PZH. 2020. [cited 2020 Aug 5]. Available from: https://szczepienia.pzh.gov.pl/szczepionki/blonica/9/?print-version
- Paradowska-Stankiewicz I, Stefanoff P Sytuacja epidemiologiczna krztuśca, błonicy, tężca i poliomyelitis w Polsce, innych krajach Unii Europejskiej i na świecie - cz. 2. Medycyna praktyczna.2010. [cited 2020 Sep 1]. Available from: https://www.mp.pl/szczepienia/choroby/choroby_blonica/71648,sytuacja-epidemiologiczna-krztusca-blonicy-tezca-ipoliomyelitis-wpolsce-innych-krajach-unii-europejskiej-inaswiecie-cz-2
- GUS. 2020. [cited 2020 Aug 5]. Available from: https://stat.gov.pl/wskazniki-makroekonomiczne/
- Kostrzewski J, editor. Choroby zakaźne w Polsce i ich zwalczanie w latach (PZWL) 1919 -1962. Warszawa: Państwowy Zakład Wydawnictwa Lekarskich; 1964.
- NIZP-PZH. 2004. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2004/Ch_2004.pdf
- NIZP-PZH. 2005. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2005/Ch_2005.pdf
- NIZP-PZH. 2006. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2006/Ch_2006.pdf
- Szata W. Hepatitis B virus in 1993. Przegl Epidemiol. 1995;49(1–2):153–157.
- Janaszek W. The impact of immunization against measles on epidemiology of measles in Poland. Przegl Epidemiol. 1998;52(4):413–425.
- Szczepańska H. Ostre choroby zakaźne dzieci. Warszawa: PZWL; 1980.
- NIZP-PZH. Choroby zakaz´ne i zatrucia w Polsce w 1999 roku. Warszawa: Pan´stwowy Zakład Higieny1999. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/1999/Ch_1999.pdf
- NIZP-PZH. Choroby zakaz´ne i zatrucia w Polsce w 2000 roku. Warszawa: Pan´stwowy Zakład Higieny2000. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2000/Ch_2000.pdf
- NIZP-PZH. Choroby zakaz´ne i zatrucia w Polsce w 2001 roku. Warszawa: Pan´stwowy Zakład Higieny2001. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2001/Ch_2001.pdf
- NIZP-PZH. Choroby zakaz´ne i zatrucia w Polsce w 2002 roku. Warszawa: Pan´stwowy Zakład Higieny2002. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2002/Ch_2002.pdf
- NIZP-PZH. Choroby zakaz´ne i zatrucia w Polsce w 2002 roku. Warszawa: Pan´stwowy Zakład Higieny2003. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2003/Ch_2003.pdf
- KOROUN. 2014. [cited 2020 Aug 5]. Available from: http://koroun.nil.gov.pl/wp-content/uploads/2017/10/ICHP_2014.pdf
- KOROUN. 2015. [cited 2020 Aug 5]. Available from: http://koroun.nil.gov.pl/wp-content/uploads/2017/10/ICHP_2015
- KOROUN. 2016. [cited 2020 Aug 5]. Available from: http://koroun.nil.gov.pl/wp-content/uploads/2017/10/ICHP2016.pdf
- NIZP-PZH. 2014. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2014/Ch_2014
- NIZP-PZH. 2015. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2015/Ch_2015.pdf
- NIZP-PZH. 2016. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2016/Ch_2016.pdf
- AOTMiT. (zlecenie nr 191/2019).2019. [cited 2020 Aug 5]. Available from: https://bipold.aotm.gov.pl/assets/files/zlecenia_mz/2019/191/RPT/OT.4320.17.2019_szczepienionka%20pneumokoki_Synflorix_Prevenar13_28.01_BIP.pdf
- Monasta L, Ronfani L, Marchetti F, et al. Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 2012;7(4):e36226. doi: 10.1371/journal.pone.0036226
- Mazurowska-Magdzik W, Bucholc B, Janaszek-Seydlitz W, et al. Problems of prevention and control of poliomyelitis in Poland. Przegl Epidemiol. 2010;64(3):341–347.
- Patrzałek M, Patrzałek MP. The cases of rotaviral diarrhea from Kielce and Kielce district, hospitalized in Kielce Voivodeship children Hospital in 2002-2006. Przegl Epidemiol. 2008;62(3):557–563.
- IGiChP. 2020. [cited 2020 Aug 5]. Available from: https://www.igichp.edu.pl/wp-content/uploads/2020/06/biuletyn_2020.pdf
- NIZP-PZH. 2012. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2012/Ch_2012.pdf
- NIZP-PZH. 2013. [cited 2022 Nov 8]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2013/Ch_2013.pdf
- Van Damme P, Giaquinto C, Huet F, et al. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis. [2007 May 1];195(Suppl 1):S4–s16. doi: 10.1086/516714
- NIZP-PZH. 2017. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2017/Ch_2017.pdf
- NIZP-PZH. 2019. [cited 2020 Aug 5]. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2019/Ch_2019_Wstepne_dane.pdf
- NIZP-PZH. 1999. [cited 2020 Aug 5]. Available from: https://wwwold.pzh.gov.pl/oldpage/epimeld/1999/Ch_1999.pdf
- NIZP-PZH. 2000. [cited 2020 Aug 5]. Available from: https://wwwold.pzh.gov.pl/oldpage/epimeld/2000/Ch_2000.pdf
- NIZP-PZH. 2001. [cited 2020 Aug 5]. Available from: https://wwwold.pzh.gov.pl/oldpage/epimeld/2001/Ch_2001.pdf
- NIZP-PZH. 2002. [cited 2020 Aug 5]. Available from: https://wwwold.pzh.gov.pl/oldpage/epimeld/2002/Ch_2002.pdf
- NIZP-PZH. 2003. [cited 2020 Aug 5]. Available from: https://wwwold.pzh.gov.pl/oldpage/epimeld/2003/Ch_2003.pdf
- Gałazka A. Can we control pertussis better? I. Changes in the epidemiology of pertussis. Przegl Epidemiol. 1997;51(3):275–284.
- Rumik A, Paradowska-Stankiewicz I, Rudowska J, et al. Pertussis in Poland in 2017. Przegl Epidemiol. 2019;73(3):289–295. doi: 10.32394/pe.73.33
- Soriano-Gabarró M, Mrukowicz J, Vesikari T, et al. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J. 2006;25(1):S7–S11. doi: 10.1097/01.inf.0000197622.98559.01
- Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. Vaccine. [2015 Apr 27];33(18):2097–2107. doi: 10.1016/j.vaccine.2015.03.016
- Paulke-Korinek M, Kundi M, Rendi-Wagner P, et al. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine. [2011 Mar 24];29(15):2791–2796. doi: 10.1016/j.vaccine.2011.01.104
- Paulke-Korinek M, Kollaritsch H, Aberle SW, et al. Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria. Vaccine. [2013 May 31];31(24):2686–2691. doi: 10.1016/j.vaccine.2013.04.001
- Sabbe M, Berger N, Blommaert A, et al. Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014. Euro Surveill. [2016 Jul 7];21(27). doi: 10.2807/1560-7917.ES.2016.21.27.30273
- Zeller M, Rahman M, Heylen E, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine. [2010 Nov 3];28(47):7507–7513. doi: 10.1016/j.vaccine.2010.09.004
- Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. [2006 Jan 5];354(1):23–33. doi: 10.1056/NEJMoa052664
- Kawai K, Adil EA, Barrett D, et al. Ambulatory visits for otitis media before and after the introduction of pneumococcal conjugate vaccination. J Pediatr. 2018 Oct;201:122–127 e121.
- Finnish Institute for Health and Welfare (THL). Incidence of invasive pneumococcal disease in Finland.2020. [cited Jul 2020]. Available from: https://thl.fi/en/web/thlfi-en/research-and-development/research-and-projects/monitoring-the-population-effectiveness-of-pneumococcal-conjugate-vaccination-in-the-finnish-national-vaccination-programme/incidence-of-invasive-pneumococcal-disease-in-finland
- Palmu AA, Rinta-Kokko H, Nohynek H, et al. Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study. PLoS One. 2017;12(3):e0172690. doi: 10.1371/journal.pone.0172690
- Okasha O, Rinta-Kokko H, Palmu AA, et al. Population-level impact of infant 10-valent pneumococcal conjugate vaccination on adult pneumonia hospitalisations in Finland. Thorax. 2018 Mar;73(3):262–269. doi: 10.1136/thoraxjnl-2017-210440
- Zieliński A, Rudowska J. Tetanus in Poland in 2014. Przegl Epidemiol. 2016;70(2):243–247.
- Zieliński A, Rudowska J. Tetanus in Poland in 2015. Przegl Epidemiol. 2017;71(3):373–378.
- Zieliński A, Rudowska J, Rudowska J. Tetanus in Poland in 2016. Przegl Epidemiol. 2018;72(3):169–174. doi: 10.32394/pe.72.3.1
- Zieliński A, Rudowska J. Tetanus in Poland in 2017. Przegl Epidemiol. 2019;73(2):193–200. doi: 10.32394/pe.73.18
- Jit M. The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis. J Infect. 2010 Jul;61(2):114–124. doi: 10.1016/j.jinf.2010.04.008
- Bilcke J, Van Damme P, Beutels P. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and “no medical care’’ disease impact in Belgium. Med Decis Making. 2009 Jan;29(1):33–50. doi: 10.1177/0272989X08324955
- Bilcke J, Van Damme P, De Smet F, et al. The health and economic burden of rotavirus disease in Belgium. Eur J Pediatr. 2008 Dec;167(12):1409–1419. doi: 10.1007/s00431-008-0684-3
- Hryniewicz W, Albrecht P, Radzikowski A Rekomendacje postepowania w pozaszpitalnych zakazeniach układu oddechowego.2016. [cited 2020 Aug 5]. Available from: http://antybiotyki.edu.pl/wp-content/uploads/Rekomendacje/Rekomendacje2016.pdf
- Michałowska-Mitczuk D, Augustynowicz-Kopeć E, Demkow U, et al. Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczące rozpoznawania, leczenia i zapobiegania gruźlicy u dorosłych i dzieci. Pneumonologia i alergologia polska. 2013;81(4):323–379. doi: 10.5603/ARM.34896
- WHO. World health Organization2020. [cited 2020 Sep 4]. Available from: https://www.whocc.no/atc_ddd_index/
- Augustynowicz-Kopec E, Demkow U, Grzelewska-Rzymowska I, et al. Guidelines of Polish respiratory society concerning diagnosis, treatment and prevention of tuberculosis in adults and in child. Pneumonol Alergol Pol. 2013;81(4):325–379.
- AOTMiT. (zlecenie nr 330/2013).2013. [cited 2020 Aug 5]. Available from: http://bipold.aotm.gov.pl/assets/files/zlecenia_mz/2013/330/AW/330_AW_DS_4351_07_Viread_AE.pdf
- AOTMiT. Opracowanie dotyczące oceny zasadności wprowadzenia zmian w dotychczasowym opisie programu lekowego: “Leczenie przewlekłego wirusowego zapalania wątroby typu B”.2019. [cited 2020 Aug 5]. Available from: https://bipold.aotm.gov.pl/assets/files/zlecenia_mz/2019/213/RPT/OT.4320.22.2019_Program_WZWB.pdf
- AOTMiT. (zlecenie nr 351/2013).2013. [cited 2020 Aug 5]. Available from: http://bipold.aotm.gov.pl/assets/files/zlecenia_mz/2013/351/AW/351_AW_OT_4350_33_Synflorix_Pneumokoki_AE_2014.02.13.pdf
- Padaczka; Noz. Warszawa. Mar 2020. [cited 2021 Sep 21]. Available from: https://ezdrowie.gov.pl/5688
- Chan B, McIntyre A, Mittmann N, et al. Economic evaluation of spinal cord injury. In: Eng J, Teasell R, Miller W, Wolfe D, Townson A, and Hsieh J, editors. Spinal cord injury rehabilitation evidence, version 5. SCIRE; 2014. p. 1–21.
- IMF. World economic outlook database. International monetary fund October 2018. [cited 2019 Apr 23]. Available from: https://www.imf.org/external/pubs/ft/weo/2019/01/weodata/index.aspx
- Zhou F, Santoli J, Messonnier ML, et al. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Archives Of Pediatrics & Adolescent Medicine. 2005 Dec;159(12):1136–1144. doi: 10.1001/archpedi.159.12.1136
- Weisbrod BA. The valuation of human capital. J Polit Economy. 1961;69(5):425–436. doi: 10.1086/258535
- Golicki D, Jaśkowiak K, Dobrowolska I, et al. Indirect costs of pneumococcal diseases in Poland: estimation based on the data of the Social Insurance institution (ZUS) regarding sickness absence. J Health Policy Outcomes Res. 2019;2(2):1. doi: 10.7365/JHPOR.2019.2.2
- GUS. Trwanie życia w.2018. [cited 2020 Aug 5]. Available from: https://stat.gov.pl/obszary-tematyczne/ludnosc/trwanie-zycia/trwanie-zycia-w-2018-r-,2,13.html
- AOTMiT. Komunikat Prezesa Agencji Oceny Technologii Medycznych i Taryfikacji w sprawie obowiązującej od dnia 30 października 2020 r. wysokości progu kosztu uzyskania dodatkowego roku życia skorygowanego o jakość.2020. [cited 2023 Feb 16]. Available from: https://www.aotm.gov.pl/aktualnosci/najnowsze/komunikat-prezesa-agencji-oceny-technologii-medycznych-i-taryfikacji-w-sprawie-obowiazujacej-od-dnia-30-pazdziernika-2020-r-wysokosci-progu-kosztu-uzyskania-dodatkowego-roku-zycia-skorygowanego-o-jak/
- Bencina G, Costantino C, Mameli C, et al. Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review. Expert Rev Vaccines. 2022 Aug;21(8):1121–1136. doi: 10.1080/14760584.2022.2075851
- van Panhuis WG, Grefenstette J, Jung SY, et al. Contagious diseases in the United States from 1888 to the present. N Engl J Med. [2013 Nov 28];369(22):2152–2158. doi: 10.1056/NEJMms1215400
- CDC. Impact of vaccines universally recommended for children–United States, 1990-1998. MMWR Morb Mortal Wkly Rep. 1999;48(12):243–248.
- Pezzotti P, Bellino S, Prestinaci F, et al. The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015. Vaccine. [2018 Mar 7];36(11):1435–1443. doi: 10.1016/j.vaccine.2018.01.065
- Roush SW, Murphy TV. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. [2007 Nov 14];298(18):2155–2163. doi: 10.1001/jama.298.18.2155
- Talbird SE, Carrico J, La EM, et al. Impact of routine childhood immunization in reducing vaccine-preventable diseases in the US. Pediatrics. 2022;150(3):e20210560. doi: 10.1542/peds.2021-056013
- Postma M, Biundo E, Chicoye A, et al. Capturing the value of vaccination within health technology assessment and health economics: country analysis and priority value concepts. Vaccine. 2022 [2022 Jun 26];40(30):3999–4007. doi: 10.1016/j.vaccine.2022.04.026
- Vaughan K, Ozaltin A, Mallow M, et al. The costs of delivering vaccines in low- and middle-income countries: findings from a systematic review. Vaccine: X. 2019 [2019 Aug 9];2:100034.
- Ozawa S, Clark S, Portnoy A, et al. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001-2020. Bull World Health Organ. [2017 Sep 1];95(9):629–638. doi: 10.2471/BLT.16.178475
- Wateska AR, Nowalk MP, Zimmerman RK, et al. Cost-effectiveness of increasing vaccination in high-risk adults aged 18-64 years: a model-based decision analysis. BMC Infect Dis. [2018 Jan 25];18(1):52. doi: 10.1186/s12879-018-2967-2
- Nohynek H, Wichmann O, DA F. National Advisory Groups and their role in immunization policy-making processes in European countries. Clin Microbiol Infect. 2013 Dec;19(12):1096–1105. doi: 10.1111/1469-0691.12315
- Yuasa A, Yonemoto N, LoPresti M, et al. Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2021 Apr;21(2):235–245. doi: 10.1080/14737167.2021.1881484